secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2026-05-11T20:02:33+00:00
Accession:  0001193125-26-216710
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Galera shareholders approve reverse split (1:75 to 1:200) and share increase to 400M
--------------------------------------------------------------------------------

- Elected J. Mel Sorensen (Class III), Nancy Chang and Michael Friedman (Class I) as directors.
- Ratified KPMG as auditor for FY 2026.
- Approved say-on-pay and annual frequency for future say-on-pay votes.
- Authorized amendment raising common shares from 200M to 400M.
- Authorized reverse stock split at Board-discretion ratio between 1:75 and 1:200.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312526216710/0001193125-26-216710-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312526216710/d137690d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-216710

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer